| Literature DB >> 35769961 |
Vykuntaraju K Gowda1, Sukanya Vignesh1, Balamurugan Nagarajan1, Varunvenkat M Srinivasan1, Manojna Battina1, Maya Bhat2, Rita Christopher3.
Abstract
Biotinidase deficiency is a treatable neurometabolic disorder. It usually presents during the first year of life with seizures, ataxia, hypotonia, vision and hearing disturbance, alopecia, and skin rashes. It can have various neuroimaging findings but demyelinating leukoencephalopathy is an unusual finding in children with biotinidase deficiency that can cause diagnostic challenge as it can radiologically mimic perinatal hypoxic-ischemic encephalopathy or other leukodystrophies. It reverses with early diagnosis and treatment with biotin supplementation and the outcome is rewarding. Thieme. All rights reserved.Entities:
Keywords: biotinidase; demyelination; leukoencephalopathy; neurometabolic disorders
Year: 2020 PMID: 35769961 PMCID: PMC9236727 DOI: 10.1055/s-0040-1721678
Source DB: PubMed Journal: J Pediatr Genet ISSN: 2146-460X